Dr. Rasha Kelej meets The First Lady of Nigeria & 6 African First Ladies of Africa at the 12th Africa Asia Luminary 2025 in ...
USA-based mRNA vaccines company Moderna’s shares were flat in pre-market activity, as the company announced awaited new ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a multi-year collaboration with ...
The original is 6 stories and holds 1,500 cars: the new one is only 4 stories and 500 cars,” said Merck spokesman Greg Landis.
5hon MSN
ESG roundup: Market talk
Find insight on Merck KGaA, Indonesia’s B50 policy, IJM Corp. and more in the latest Market Talks covering ESG Impact ...
United Arab Emirates: The Ministry of Health and Prevention (MoHAP), in collaboration with Merck Gulf, showcased the results ...
Invesco Equity and Income Fund lagged its benchmark in Q4 2025 as IT and fixed income weighed. See new holdings and full ...
With star checkpoint inhibitors like Keytruda and Opdivo now sporting subcutaneous formulations, GSK has struck a deal aimed ...
US pharma major Merck & Co is trying to make its looming Keytruda (pembrolizumab) patent hill look more like a speed bump.
In a clarification filed on January 19, Sun Pharma said there was “no material event or information” requiring disclosure ...
GlobalData on MSN
Moderna’s cancer vaccine plus Keytruda boosts RFS in melanoma study
A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.
Sun Pharma has addressed speculation regarding a potential $10 billion acquisition of US firm Organon. The Indian drugmaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results